Novartis will make an upfront payment of $800-million to acquire all of the outstanding share capital of the company, as well as potential additional milestone payments of up to $700-million, it said in a statement.
Gyroscope Therapeutics has been developing a one-time gene therapy to treat an age-related condition known as geographic atrophy, which causes lesions on the retina and can cause blindness, it said.Novartis said the transaction's closing was still subject to regulatory approvals.
Portugal Últimas Notícias, Portugal Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
MAS Real Estate sells UK investment property for €45.2mProceeds of sale after taxes and mandatory settlements of senior debt facilities will be used for acquisitions
Fonte: BDliveSA - 🏆 12. / 63 Consulte Mais informação »